Latest filing published 27 Aug 2026 for Artiva Biotherapeutics, Inc., €79k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Subhashis Banerjee in Artiva Biotherapeutics, Inc. Between 18 August 2026 and 27 August 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 27 August 2026, reports a transaction of €79k in Artiva Biotherapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations